Quince Therapeutics
QNCX
QNCX
50 hedge funds and large institutions have $3.44M invested in Quince Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 23 reducing their positions, and 18 closing their positions.
Holders
50
Holders Change
-11
Holders Change %
-18.03%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
23
Closed
18
Calls
$228K
Puts
$72K
Net Calls
+$156K
Net Calls Change
+$198K
Top Buyers
1 |
1
Millennium Management
New York
|
$380K |
2 |
E
2
Ergoteles
New York
|
$25K |
3 |
TLP
3
Tri Locum Partners
New York
|
$14K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$29.4K |
5 |
BCI
5
Brinker Capital Investments
Berwyn,
Pennsylvania
|
$6.84K |